Home > Insider Trading > Filing (0001140361-23-040321)

Filing Details

Accession Number:: 0001140361-23-040321
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-17 21:30:44
Reporting Period:: 2023-08-15

Accepted Time:: 2023-08-17 21:30:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368514	Adma Biologics Inc.	ADMA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1283260	Brian Lenz	C/O Adma Biologics, Inc. 465 State Route 17 Ramsey NJ 07446	Evp, Cfo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-08-15	211,578	$4.60	782,013	No	4	S	Direct
Common Stock	Acquisiton	2023-08-15	97,395	$1.67	879,408	No	4	M	Direct
Common Stock	Acquisiton	2023-08-15	83,979	$2.35	963,387	No	4	M	Direct
Common Stock	Acquisiton	2023-08-15	85,416	$2.92	1,048,803	No	4	M	Direct
Common Stock	Acquisiton	2023-08-15	200,000	$3.22	1,248,803	No	4	M	Direct
Common Stock	Acquisiton	2023-08-15	150,000	$3.71	1,398,803	No	4	M	Direct
Common Stock	Acquisiton	2023-08-15	192,472	$3.66	1,591,275	No	4	M	Direct
Common Stock	Disposition	2023-08-15	631,078	$4.61	960,197	No	4	F	Direct
Common Stock	Disposition	2023-08-16	178,184	$4.45	782,013	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-08-15	97,395	$1.67	97,395	$1.67
Common Stock	Stock Option (Right to Buy)	Disposition	2023-08-15	83,979	$2.35	83,979	$2.35
Common Stock	Stock Option (Right to Buy)	Disposition	2023-08-15	85,416	$2.92	85,416	$2.92
Common Stock	Stock Option (Right to Buy)	Disposition	2023-08-15	200,000	$3.22	200,000	$3.22
Common Stock	Stock Option (Right to Buy)	Disposition	2023-08-15	150,000	$3.71	150,000	$3.71
Common Stock	Stock Option (Right to Buy)	Disposition	2023-08-15	192,472	$3.66	192,472	$3.66

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
177,605	2032-03-07	No	4	M	Direct
55,021	2031-02-25	No	4	M	Direct
14,584	2030-02-28	No	4	M	Direct
0	2029-01-23	No	4	M	Direct
0	2028-02-09	No	4	M	Direct
0	2027-06-06	No	4	M	Direct

Footnotes

Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $4.60 to $4.65, inclusive.
Reflects the weighted average price of sales on August 16, 2023. The shares were sold in multiple transactions at prices ranging from $4.40 to $4.535, inclusive.
Includes (i) 135,175 RSUs granted on March 6, 2023 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 103,125 unvested RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 185,625 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which shall vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;
(continued from footnote 3) (iv) 30,480 unvested RSUs granted on February 25, 2021, of which 27,500 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 2,980 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;
(continued from footnote 4) (v) 10,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 317,608 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
The options vest over four years with 25% of the shares of common stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on March 7, 2026.
The options vest over four years with 25% of the shares of Common Stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 25, 2025.
The options vest over four years with 25% of the shares of Common Stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 28, 2024.
The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on February 23, 2020, becoming fully vested on January 23, 2023.
The option vests over a four year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on March 9, 2019, becoming fully vested on February 9, 2022.
The option vests over a four year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter beginning on July 6, 2018, becoming fully vested on June 6, 2021.